Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan versus amlodipine crossover pilot study in metabolic syndrome with hypertension
2005-005206-23Phase 4Active
- Sponsor
- 3.Med. Department, Academic Hospital Bogenhausen
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of telmisartan and amlodipine in hypertension (HTN) and cardiometabolic risk (CMR) (2 arms), sponsored by 3.Med. Department, Academic Hospital Bogenhausen. Primary endpoint: Diastolic myocardial function. Started Nov 2005; status: active.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2005-005206-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005206-23.